Payden & Rygel’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-9,380
Closed -$222K 225
2015
Q4
$222K Hold
9,380
0.03% 72
2015
Q3
$187K Sell
9,380
-184,400
-95% -$3.69M 0.03% 73
2015
Q2
$3.75M Hold
193,780
0.5% 64
2015
Q1
$4.39M Sell
193,780
-36,600
-16% -$841K 0.57% 62
2014
Q4
$4.96M Buy
230,380
+76,500
+50% +$1.63M 0.95% 55
2014
Q3
$3.11M Buy
153,880
+20,330
+15% +$442K 0.62% 65
2014
Q2
$2.92M Buy
133,550
+20,450
+18% +$434K 0.74% 60
2014
Q1
$2.32M Hold
113,100
0.9% 51
2013
Q4
$2.05M Hold
113,100
0.7% 61
2013
Q3
$2.1M Sell
113,100
-8,100
-7% -$159K 0.75% 56
2013
Q2
$2.45M Buy
+121,200
New +$2.62M 0.96% 59

Other funds holding BMR

Payden & Rygel's BMR Position: Q1 2016 in Review

Payden & Rygel sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 9,380 shares — an estimated $222K sold.

Payden & Rygel first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $4.96M in Q4 2014. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Payden & Rygel reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Payden & Rygel sold 9,380 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $222K.
  • Payden & Rygel first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Payden & Rygel's BIOMED REALTY TRUST INC position peaked at $4.96M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Payden & Rygel's 13F filing for Q1 2016, filed 6 May 2016.